PredictImmune Secures £4.3m Investment from Wellcome Trust to Evaluate The...
PredictImmune a developer of prognostic tools to guide treatment of patients with immunemediated diseases announced today that it has been awarded £4.3m by the Wellcome Trust. The funding will be used...
View ArticleBiomarker Test for Crohns Disease Gets Massive Support From Wellcome Trust
PredictImmune has been awarded£4.3M 4.8M by the Wellcome Trust to run a clinical trial with its prognostic biomarker test for Crohn&8217;s disease. UK biotech PredictImmune a developer of...
View ArticleOncobiologics Inc ONS Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryOncobiologics Inc Oncobiologics is a biopharmaceutical company that develops and markets biosimilar therapeutics. The company's product pipeline comprises ONS3010 and ONS1045. It uses...
View ArticleGilead Verily Launch Inflammatory Disease Collaboration
Gilead Sciences will partner with Google parent Alphabets Verily Life Sciences over the next three years to study immunological and molecular drivers of three inflammatory diseases the companies said....
View ArticleLandos Biopharma Announces Publication of Mechanistic and Human Translational...
Landos Biopharma Inc. an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases announced the publication of findings on the mechanisms of action for its...
View ArticleNew York Patients Are Being Forced Off Prescribed Medications During the Plan...
Global Healthy Living Foundation survey finds nearly all respondents 98.2 support legislation prohibiting insurance companies from financially pressuring them to switch from their prescribed medication...
View ArticleManagement of Crohn Disease in Adults
An updated clinical guideline addresses the natural history and medical and surgical management of Crohn disease.
View ArticleYour NEJM Group Today GiantCell Myocarditis Clinical Pearls Crohn's Guideline...
Here's what's happening around NEJM Group NEJM Resident 360 Clinical pearls What are some of the features of giantcell myocarditis Are there any imaging...
View ArticleSoutheastern Grocers Introduces Pathstone Health Services to Serve Customers...
Specialty Pharmacy services available in all BILO Fresco y Ms Harveys and WinnDixie pharmacies Southeastern Grocers LLC SEG parent company and home of BILO Fresco y Ms Harveys Supermarket and WinnDixie...
View ArticleMorphoSys AG Reports First Quarter 2018 Results news with additional features
DGAPNews MorphoSys AG Key words Quarter Results02.05.2018 2200 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany May 2 2018MorphoSys AG Reports First Quarter...
View ArticleBowel disease study points to new therapies for lifelong conditions
University of Edinburgh Treatments for incurable bowel conditions may be a step closer following the discovery of a key molecule associated with disease flareups. Researchers at the University of...
View ArticleEsperite's ESP The Cell Factory received European funding to develop the 2nd...
Esperite's biotech company The Cell Factory Belgium has received funding from the European Union's Horizon 2020 research and innovation Programme for development and characterization...
View ArticleLandos Biopharma publishes findings on BT11 for Crohn's Disease and UC
Landos Biopharma Inc. an emerging biopharmaceutical company focused on developing improved treatments for autoimmune diseases announced the publication of findings on the mechanisms of action for its...
View ArticleCelgene Reports First Quarter 2018 Operating and Financial Results
Q118 total net product sales of $3531 million increased 20 YY Raising fullyear 2018 revenue guidance to high end of previous range Completion of Juno Therapeutics & Impact Biomedicines...
View ArticleFDA Grants Priority Review to Genentechs Cancer Immunotherapy TECENTRIQ...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the U.S. Food and Drug Administration FDA has accepted the companys supplemental Biologics License Application sBLA...
View ArticleResearchers uncover role of ROS in clearing dead cells
If dead cells accumulate in the body they can contribute to inflammation and predispose individuals to multiple chronic inflammatory conditions such as rheumatoid arthritis cardiovascular diseases...
View ArticleNavidea Biopharmaceuticals Reports First Quarter 2018 Financial Results
Conference Call to be held Wednesday May 9 2018 at 830 am ET Navidea Biopharmaceuticals Inc. NYSE American NAVB Navidea or the Company a company focused on the development of precision immunodiagnostic...
View ArticleMedical News Today What causes undigested food to appear in stool
Certain foods including highfiber foods and sweetcorn are more difficult to digest than others. It is normal for a person to notice undigested bits of these foods in their stool. If undigested food in...
View ArticleGenentech Provides Update on Phase III Study of TECENTRIQ Atezolizumab and...
Genentech a member of the Roche Group SIX RO ROG; OTCQX RHHBY today announced that the Phase III IMblaze370 study evaluating the combination of TECENTRIQÂ atezolizumab and COTELLICÂ cobimetinib did not...
View ArticleNeuClone Announces Preclinical Results for Stelara ustekinumab Biosimilar...
SYDNEY May 10 2018 PRNewswire Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson's Stelara® including 3dimensional 3D...
View Article